OVERVIEW

Louisiana Initial Medical Licensure Program is organized by InforMed Continuing Medical Education (CME).

? Course 1: Best Practices for Prescribing Controlled Substances

Release Date: 12/2018
Expired Date: 12/2022

Target Audience:
This course is designed for all physicians and health care providers involved in the treatment and monitoring of patients prescribed controlled substances.

Course Objective:
The purpose of this course is to educate prescribers on best practices for the safe prescribing of controlled substances, including opioid analgesics. The course focuses on regulatory and legal framework, current best practices for prescribing controlled substances, pharmacologic (nonopioid and opioid analgesics) and non-pharmacologic therapies for pain management, diversion and treatment of substance use disorders.

Learning Objectives:
Completion of this course will better enable the course participant to:
• Explain the purpose, role, and need for the Controlled Substances Act (CSA) as it relates to clinical practice.
• Explain the similarities and differences between the five (5) DEA schedules for controlled substances.
• Describe the key steps recommended for the responsible prescribing of controlled substances.
• Describe pharmacological treatment options for treating pain, anxiety disorder, insomnia, narcolepsy, and attentiondeficit hyperactivity disorder.
• Describe the fundamental concepts of pain management, including definitions and mechanisms of pain.
• Identify the range of therapeutic options for managing pain, including non-pharmacologic approaches and pharmacologic (non-opioid and opioid analgesics) therapies.
• Explain how to integrate opioid analgesics into a pain treatment plan individualized to the needs of the patient, including counseling patients and caregivers about the safe use of opioid analgesics.
• Describe how to safely and effectively manage patients on opioid analgesics in the acute and chronic pain settings, including assessing, initiating therapy, titrating, ongoing and discontinuing use.
• Describe at least four (4) practices clinicians can use to minimize diversion of controlled substances.
• Identify the six (6) approved pharmacotherapies for treating alcohol and opioid use disorders.

? Learner Records: Answer Sheet & Evaluation